Spots Global Cancer Trial Database for ovarian mixed germ cell tumor

Every month we try and update this database with for ovarian mixed germ cell tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment	NCT00453310	Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ...	sunitinib malat...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors	NCT00551122	Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ...	filgrastim lenograstim pegfilgrastim cisplatin gemcitabine hyd... ifosfamide paclitaxel	16 Years - 60 Years	University of Southampton
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors	NCT00551122	Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ...	filgrastim lenograstim pegfilgrastim cisplatin gemcitabine hyd... ifosfamide paclitaxel	16 Years - 60 Years	University of Southampton
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer	NCT00060372	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Atypical Chroni... Childhood Myelo... Chronic Myeloge... Disseminated Ne... Malignant Neopl... Ovarian Chorioc... Ovarian Embryon... Ovarian Immatur... Ovarian Mature ... Ovarian Mixed G... Ovarian Monoder... Ovarian Polyemb... Ovarian Yolk Sa... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Malig... Recurrent Mantl... Recurrent Neuro... Recurrent Ovari... Recurrent Ovari... Refractory Chro... Refractory Mult... Relapsing Chron... Stage I Multipl... Stage II Multip... Stage II Ovaria... Stage III Malig... Stage III Multi... Stage III Ovari... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Ovaria... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Tera... Testicular Yolk... Testicular Yolk... Testicular Yolk...	ipilimumab therapeutic all...	18 Years -	National Cancer Institute (NCI)
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors	NCT00313599	Bladder Cancer Brain and Centr... Breast Cancer Esophageal Canc... Extragonadal Ge... Gastric Cancer Lung Cancer Ovarian Cancer Prostate Cancer	lapatinib paclitaxel	18 Years -	University of California, San Francisco
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy	NCT01080521	Cognitive Side ... Malignant Ovari... Ovarian Brenner... Ovarian Carcino... Ovarian Chorioc... Ovarian Clear C... Ovarian Dysgerm... Ovarian Embryon... Ovarian Endomet... Ovarian Mixed G... Ovarian Mucinou... Ovarian Polyemb... Ovarian Sarcoma Ovarian Seromuc... Ovarian Serous ... Ovarian Teratom... Ovarian Yolk Sa... Stage I Ovarian... Stage IA Fallop... Stage IA Ovaria... Stage IA Ovaria... Stage IB Fallop... Stage IB Ovaria... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage IC Ovaria... Stage II Ovaria... Stage IIA Fallo... Stage IIA Ovari... Stage IIA Ovari... Stage IIB Fallo... Stage IIB Ovari... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage IIC Ovari... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Ovaria... Stage IV Primar... Undifferentiate...	Cognitive Asses... Quality-of-Life...	18 Years -	GOG Foundation
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors	NCT00313599	Bladder Cancer Brain and Centr... Breast Cancer Esophageal Canc... Extragonadal Ge... Gastric Cancer Lung Cancer Ovarian Cancer Prostate Cancer	lapatinib paclitaxel	18 Years -	University of California, San Francisco
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors	NCT00551122	Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ...	filgrastim lenograstim pegfilgrastim cisplatin gemcitabine hyd... ifosfamide paclitaxel	16 Years - 60 Years	University of Southampton
Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors	NCT00470366	Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ...	pegfilgrastim cisplatin ifosfamide paclitaxel	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: